BirdoTech is a cutting-edge CRDMO service organization specializing in small molecule modality. Our vision is to help our clients realize maximum value, through our world-class innovation-driven drug discovery and manufacturing service platform. We collaborate with leading pharmaceutical companies and institutes, offering services such as FTE and FFS for discovery medicinal chemistry, and CDMO for the commercial manufacturing of KSMs (ISO) and registered intermediates (c-GMP). Renowned for meeting tight timelines, we support critical trials with our breakthrough scientific innovations and expediting time to market. Our laboratories are outfitted with state-of-the-art instruments to provide reliable data crucial for decision-making. To meet client demands, we employ > 330 scientists and have expanded our R&D laboratory space to 20,000 M2.

At BirdoTech, we are committed to:

Clients: Delivering reliable, high-quality products and services RFT and OTIF;

Employees: Providing safe working environment and rewarding career opportunities;

Suppliers: Establishing trusted partnerships for mutual success;

Communities: Benefiting both the community and environment.